Yatharth Hospital FY26 net profit rises 30% to ₹1,703 million
Yatharth Hospital reported a 30% rise in FY26 net profit to ₹1,703 million, with revenue growing 36% to ₹12,072 million. Q4FY26 PAT increased 15% YoY to ₹447 million, while revenue surged 47% to ₹3,416 million. EBITDA for FY26 rose 30% to ₹2,921 million.

*this image is generated using AI for illustrative purposes only.
Yatharth Hospital & Trauma Care Services Limited reported a 30% increase in consolidated net profit to ₹1,703 million for the financial year ended March 31, 2026, compared to ₹1,306 million in the previous year. Total revenue from operations surged 36% to ₹12,072 million from ₹8,856 million in FY25, driven by the expansion of its healthcare services and operational ramp-up of new hospitals. Profit after tax for Q4FY26 rose 15% year-on-year to ₹447 million, while revenue for the quarter stood at ₹3,416 million, a 47% increase from ₹2,330 million in the corresponding period of the previous year.
Q4 and FY26 Financial Performance
The board approved the financial results at a meeting held on May 25, 2026. EBITDA for FY26 increased 30% to ₹2,921 million, with an EBITDA margin of 24.2%. For Q4FY26, EBITDA grew 37% year-on-year to ₹799 million, with a margin of 23.4%. The company reported an operating cash flow of ₹2,866 million for FY26, reflecting a cash conversion ratio of 98%, compared to 70% in the previous year. The total cash position stood at ₹3,931 million, with a net cash position of ₹1,160 million.
| Metric | FY26 | FY25 | YoY (%) | Q4FY26 | Q4FY25 |
|---|---|---|---|---|---|
| Net Profit | ₹1,703 mn | ₹1,306 mn | 30% | ₹447 mn | ₹387 mn |
| Revenue from Operations | ₹12,072 mn | ₹8,856 mn | 36% | ₹3,416 mn | ₹2,330 mn |
| EBITDA | ₹2,921 mn | ₹2,254 mn | 30% | ₹799 mn | ₹583 mn |
| EBITDA Margin | 24.2% | 25.4% | (125)bps | 23.4% | 25.0% |
Operational Expansion
During the fiscal year, the group expanded its operational footprint significantly. A hospital acquired in Model Town, New Delhi, commenced commercial operations on July 14, 2025, with a capacity of 300 beds. Additionally, a hospital in Sector 20, Faridabad, Haryana, started operations on September 22, 2025, featuring 400 beds. The group also began commercial operations at the Shantived hospital in Agra, Uttar Pradesh, on February 1, 2026, with a capacity of 150 beds, expandable up to 250 beds. The recently acquired Gurugram facility is expected to commence operations at the beginning of the next fiscal year.
Key Operational Metrics
The group reported strong operational metrics for the year. Average Revenue Per Occupied Bed (ARPOB) increased to ₹33,283, up 5% year-on-year, driven by an increasing share of high-value specialities. Occupancy levels improved to 68% for FY26, up from 61% in the previous year. Newer hospitals in Greater Faridabad, Faridabad Sector-20, New Delhi, and Agra contributed ₹753 million in revenues, accounting for 22% of the group’s revenues in Q4FY26. Adjusted EBITDA margin, excluding the impact of new hospitals, stood at 30.4% for Q4FY26.
Future Outlook and Strategy
Management expects the total bed capacity to reach over 3,200 beds with upcoming facilities in Gurugram, Noida Extension, and Greater Noida. The company targets a bed capacity of 5,000 over the next three years, with approximately 70% of the expansion expected through acquisitions and 30% through greenfield projects. The Gurugram facility, acquired for an upfront consideration of approximately ₹100 crores, is expected to become operational by April 2027 with an ARPOB exceeding ₹50,000. The company maintains a net cash position of ₹1,160 million as of FY26.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0JO301016/4f20772c50f44391.pdf
Historical Stock Returns for Yatharth Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.68% | +3.97% | -1.94% | +20.84% | +58.40% | +151.54% |
How will the company utilize its net cash position of ₹1,160 million to fund the targeted 70% acquisition-based expansion over the next three years?
What is the expected timeline for the newer hospitals in Greater Faridabad, New Delhi, and Agra to reach the group's adjusted EBITDA margin of 30.4%?
With the Gurugram facility targeting an ARPOB exceeding ₹50,000, what specific high-value specialties will be introduced to achieve this premium compared to the current average?


































